Celgene Drugs Join Hedge Fund's AIA Patent Hit List
In its latest challenge to a drug patent under the America Invents Act, an organization tied to hedge fund manager Kyle Bass on Thursday took aim at a patent covering several...To view the full article, register now.
Already a subscriber? Click here to view full article